Published in Am J Psychiatry on June 01, 1999
Testosterone levels in suicide attempters with bipolar disorder. J Psychiatr Res (2012) 1.72
Testosterone therapy for reduced libido in women. Ther Adv Endocrinol Metab (2010) 0.87
A Positive Affective Neuroendocrinology Approach to Reward and Behavioral Dysregulation. Front Psychiatry (2015) 0.78
Psychiatric side effects of medications prescribed in internal medicine. Dialogues Clin Neurosci (2003) 0.75
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry (1994) 8.88
Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Trauma Stress (1998) 3.07
Development and preliminary psychometric properties of an instrument for the measurement of childhood trauma: the Early Trauma Inventory. Depress Anxiety (2000) 2.30
Rab27a enables myosin Va-dependent melanosome capture by recruiting the myosin to the organelle. J Cell Sci (2001) 2.09
The Cbk1p pathway is important for polarized cell growth and cell separation in Saccharomyces cerevisiae. Mol Cell Biol (2001) 2.00
Childhood sexual abuse as a risk factor for depression in women: psychosocial and neurobiological correlates. Am J Psychiatry (1999) 1.87
Management of the adverse effects of clozapine. Schizophr Bull (1998) 1.83
Sex differences in event-related risk for major depression. Psychol Med (2001) 1.75
A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry (1991) 1.68
Selective speech perception alterations in schizophrenic patients reporting hallucinated "voices". Am J Psychiatry (1999) 1.59
Family accommodation of obsessive-compulsive symptoms: instrument development and assessment of family behavior. J Nerv Ment Dis (1999) 1.52
Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology (1997) 1.50
ECT for lorazepam-refractory catatonia. Convuls Ther (1996) 1.48
Gender differences in the effects of bereavement-related psychological distress in health outcomes. Psychol Med (1999) 1.29
L-dopa in senile dementia. Lancet (1970) 1.29
Methadone levels in breast milk. J Hum Lact (1997) 1.20
Self-efficacy as a mediator between stressful life events and depressive symptoms. Differences based on history of prior depression. Br J Psychiatry (2000) 1.20
Interactive effects of subanesthetic ketamine and haloperidol in healthy humans. Psychopharmacology (Berl) (1999) 1.17
Exposure of emergency medicine personnel to ionizing radiation during cervical spine radiography. Ann Emerg Med (1989) 1.09
Trends in prescribing psychotropic medications. JAMA (1998) 1.09
Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans. Psychopharmacology (Berl) (1998) 1.09
Gender differences in referral to cardiac rehabilitation programs after revascularization. J Cardiopulm Rehabil (2001) 1.07
"Psychedelic" experiences in acute psychoses. Arch Gen Psychiatry (1966) 1.03
GABA levels in CSF of patients with psychiatric disorders. Am J Psychiatry (1980) 1.02
Immunizations and travel. Emerg Med Clin North Am (1997) 0.99
Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures. Neuropharmacology (1972) 0.98
Central dopamine turnover in schizophrenic syndromes. Arch Gen Psychiatry (1974) 0.98
Delta 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966. Neuropsychopharmacology (1997) 0.97
Relationship of monoamine metabolites in human cerebrospinal fluid to age. Nature (1968) 0.95
CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine. A preliminary report. J Pediatr (1977) 0.93
Psychotogenic drug use and neuroleptic response. Schizophr Bull (1990) 0.92
Central biogenic amine metabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette: norepinephrine, serotonin, and dopamine. J Am Acad Child Psychiatry (1979) 0.92
Chronic substance-induced psychotic disorders: state of the literature. J Neuropsychiatry Clin Neurosci (1996) 0.92
Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration. Arch Gen Psychiatry (1978) 0.91
Gilles de la Tourette's syndrome: biochemical approaches. Res Publ Assoc Res Nerv Ment Dis (1976) 0.91
Stress-induced activation of prefrontal cortex dopamine turnover: blockade by lesions of the amygdala. Brain Res (1994) 0.89
Desipramine plasma concentration and antidepressant response. Arch Gen Psychiatry (1982) 0.88
Insight and interpretation of illness in recovery from psychosis. Schizophr Bull (1989) 0.87
Delusional unipolar depression: description and drug response. Arch Gen Psychiatry (1978) 0.87
Measurement of acid monoamine metabolites in human and animal cerebrospinal fluid. J Neurochem (1968) 0.86
Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa. N Engl J Med (1977) 0.86
Antidepressant-associated mania and psychosis resulting in psychiatric admissions. J Clin Psychiatry (2001) 0.86
Similarities and differences between anonymous and directed candidates for oocyte donation. J Assist Reprod Genet (1995) 0.85
Dopamine and serotonin metabolism in neuropsychiatrically disturbed children. CSF homovanillic acid and 5-hydroxyindoleacetic acid. Arch Gen Psychiatry (1977) 0.85
Biochemical processes in schizophrenia: an update. Schizophr Bull (1980) 0.85
The effect of L-dopa on monoamine metabolites in Parkinson's disease. Experientia (1970) 0.85
Pretreatment plasma HVA predicts neuroleptic response in manic psychosis. J Affect Disord (1998) 0.84
Does melancholia predict response in major depression? J Affect Disord (1990) 0.84
Clozapine in the treatment of aggression in an adolescent with autistic disorder. J Clin Psychiatry (2001) 0.84
Physical and sexual abuse during childhood and development of psychiatric illnesses during adulthood. J Nerv Ment Dis (1997) 0.84
Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) during L-dopa therapy of Parkinson's disease. Neurology (1970) 0.83
Deficient transport mechanism for the removal of acid monoamine metabolites from cerebrospinal fluid. Brain Res (1969) 0.83
Plasma catecholamine metabolites in subtypes of major depression. Biol Psychiatry (1987) 0.83
Choline in cerebrospinal fluid. Life Sci (1967) 0.83
The schizophrenic experience. A follow-up study of attitude and posthospital adjustment. J Nerv Ment Dis (1969) 0.83
Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis. Biol Psychiatry (1991) 0.82
CSF amine metabolites, clinical symptoms, and body movement in psychiatric patients. Biol Psychiatry (1976) 0.82
Cerebrospinal fluid 5-hydroxyindoles and behavior after L-tryptophan and pyridoxine adminstration to psychiatric patients. Neuropharmacology (1970) 0.82
Characteristics of desipramine-refractory depression. J Clin Psychiatry (1994) 0.81
Plasma catecholamine metabolites and early response to haloperidol. J Clin Psychiatry (1984) 0.81
Lithium treatment in a very elderly nursing home population. Compr Psychiatry (1983) 0.81
CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective. Arch Gen Psychiatry (1980) 0.81
Vulnerability to psychosis associated with hallucinogen use. Psychiatry Res (1983) 0.81
Desipramine treatment of major depression in patients over 75 years of age. J Clin Psychopharmacol (1995) 0.81
Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy. Neurology (1975) 0.81
Factors influencing maintenance and release of acetylcholine in rat cortical brain slices. Int J Neuropharmacol (1967) 0.81
Transient fever and hematologic abnormalities during clozapine use. J Clin Psychopharmacol (1993) 0.80
The expanding indications for clozapine. Exp Clin Psychopharmacol (1997) 0.80
Ontogeny of dopamine and serotonin metabolites in the cerebrospinal fluid of children with neurological disorders. Dev Med Child Neurol (1980) 0.80
5-Hydroxyindoleacetic acid in rat forebrain and cerebrospinal fluid following dorsal and median midbrain raphe lesions. Brain Res (1972) 0.80
Cerebrospinal fluid 5-hydroxyindoleactiic acid and homovanillic acid in psychiatric patients. Int J Neuropharmacol (1969) 0.80
Grieving and unplanned pregnancy. Psychiatry (1976) 0.80
Monozygotic twins concordant for response to clozapine. Lancet (1996) 0.80
Do attitudes toward disclosure in donor oocyte recipients predict the use of anonymous versus directed donation? Fertil Steril (1998) 0.79
Homovanillic acid in rat caudate and prefrontal cortex following phencyclidine and amphetamine. Psychopharmacology (Berl) (1984) 0.79
Methadone increases mouse brain 5-hydroxyindoleacetic acid. Nature (1971) 0.79
Recent life stressors and biological markers in newly admitted psychotic patients. Biol Psychiatry (1997) 0.79
Latanoprost-induced iris color darkening: a case report with long-term follow-up. J Glaucoma (2000) 0.78
Cerebrospinal-fluid folate and acid monoamine metabolites. Lancet (1972) 0.78
Baclofen withdrawal and neuropsychiatric symptoms: a case report and review of other case literature. Compr Psychiatry (1986) 0.78
Serotonin function in aggression: the effect of acute plasma tryptophan depletion in aggressive patients. Biol Psychiatry (1994) 0.78
Fluorometric measurement of 5-hydroxyindoleacetic acid (5HIAA) and tryptophan in human CSF: effects of high doses of probenecid. Biol Psychiatry (1974) 0.78
Cortical instability and the mechanism of mania: a neural network simulation and perceptual test. Biol Psychiatry (2001) 0.78
Pathogenesis of acute schizophrenic psychosis. An experimental approach. Arch Gen Psychiatry (1968) 0.78
Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response. Eur J Pharmacol (1987) 0.78
Chronological association between increases in drug abuse and psychosis in Connecticut state hospitals. J Neuropsychiatry Clin Neurosci (1998) 0.77
Accumulation of 3-methoxy-4-hydroxyphenylglycol-sulfate in rabbit cerebrospinal fluid following probenecid. Brain Res (1973) 0.77
Sleep deprivation and brain acetylcholine. Science (1966) 0.77
Depression in late life: age of onset as marker of a subtype. J Affect Disord (1989) 0.77
Olanzapine for treatment-refractory psychosis in patients responsive to, but intolerant of, clozapine. J Clin Psychopharmacol (1999) 0.77
Major adverse reactions during desipramine treatment: relationship to plasma drug concentrations, concomitant antipsychotic treatment, and patient characteristics. Arch Gen Psychiatry (1982) 0.77
Early neuroleptic response: clinical profiles and plasma catecholamine metabolites. J Clin Psychopharmacol (1987) 0.77
Stressful life events and depression. Am J Psychiatry (2000) 0.77